Background: Acute traumatic thoracic aortic transection is a life-threatening condition resulting in a sudden deceleration. Concurrent injuries can make treatment prioritization difficult and require early recognition and prompt intervention. Surgical replacement of aorta is associated with high rates of morbidity and mortality and in this view endovascular treatment seems to be a safe and effective alternative. Objective: The aim of this study was to analyze our experience of emergency thoracic endovascular aortic repair (TEVAR) in patients with acute traumatic thoracic aortic transection. Methods: From January 2014 to December 2016, a total of 35 acute thoracic aortic transection patients were brought to our hospital. Patient demographics including age, injury detail and preoperative Computed Tomography Angiography (CTA) were analyzed. Emergency TEVAR was performed and postoperative follow-up consisted clinical and CTA at discharge, 1, 3 and 6 months and yearly thereafter. Result: 1. Totally 35 patients were enrolled. The median age was 42y (range, 20-71y), 31 of 35 patients (88.6%) were men. 30 patients had been involved in vehicle accidents, while the other 5 patients had fallen from heights. All patients had concomitant injuries. 2. The aortic transection was diagnosed by CTA, and in all cases the transection segment was located at the distal of the origin of left subclavian artery (LSA). 3. 1 patient died before he was transferred to catheter room. 34 (97.14%) patients underwent TEVAR procedure successfully. The percutaneous femoral access was performed for stent delivery in all patients, the mean proximal aortic diameter was 23.71±2.53mm, the mean length of injured segment was 44.49±7.36mm. A single stent graft implantation was sufficient to exclude the injured segment in all cases. The median proximal diameter of stent-graft was 30mm (range 26-32mm), which oversized 22.27±8.55%. The median cover length was 160 mm (range 150-200 mm). The origin of LSA was covered in 4 patients to achieve adequate proximal landing zone, no LSA revascularization performed. The median procedure time was 50min (range 40-75min). 4. After a median follow-up of 12 months (range 1-36 months), the overall survival was 100%. One patient complaint mild left upper limb weakened resulting in LSA occlusion. No procedure related deaths, paraplegia, no endoleak or distal migration were detected at CT follow up.
Yonsei University College of Medicine, Radiology, Seoul, Korea Republic of Background: In patients with abdominal aortic aneurys (AAA), atherosclerotic disease such as coronary artery disease (CAD) or peripheral artery disease (PAD) are frequently combined. We sought to investigate impact of concomit-tent CAD or PAD on clinical outcomes in patients treated with endovascular aortic aneurysm repair (EVAR). Methods: Patients were divided into group A (n=166), patients without combined CAD or PAD, group B (n=196), patients with combined CAD, but without PAD, and group C (n=113), patients with combined PAD regardless of CAD. The primary endpoint was the accumulated rate of major adverse cardiovascular and cerebrovascular event (MACCE), a composite of all-cause death, myocardial infarction (MI) and stroke. Results: The prevalence of CAD and PAD was 55.8% (265/475) and 23.8% (113/475), respectively. Mean follow-up duration was 40.2±25.3 months. At 3 years, there were 36 MACCEs (28 all-cause deaths, 7 aneurysm-related deaths, 1 MI, 8 strokes). The incidences of stroke and MACCE were significantly different among the groups (MACCE; A 5.6% vs. B 9.5% vs. C 16.7%, P=0.021, Stroke; A 0% vs. B 2.2% vs. C 5.2%, P=0.025). AAA patients with combined PAD showed significantly higher rates of stroke (P=0.008) and MACCE (P=0.008) compared with those without combined CAD or PAD. Combined PAD and previous stroke were independent predictors of MACCE.
Conclusions:
Combined presence of PAD showed a poor prognosis in terms of increased MACCE and stroke for patients with AAA patients undergoing EVAR. More active secondary prevention may be needed to reduce adverse cardiovascular event in AAA patients with combined PAD. Objectives: To determine morphologic predictive factors of aortic mortality in acute phase of IMH. Methods: One hundred and forty-three patients with an IMH were included prospectively in a clinical and imaging protocol: 36 (25%) type A and 107 type B (75%). Clinical and morphological parameters as MAD, initial haematoma thickness and the presence of ID were collected. ID was defined as the presence of an intimal defect in the aortic wall >3mm. Results: Aortic mortality during hospitalization was 6% (9 cases), 5 type A (14%) and 4 type B (4%) IMH; p=0.03. Development of ID (21% vs 4%; p=0.004) and MAD (54.4±14.5 vs 44.7±11.2mm; p=0.015) were related with aortic mortality in acute phase. Other parameters as initial hematoma thickness, age or invasive treatment were not associated with mortality. Basal MAD was a good predictor of mortality in acute phase (area under the curve=80%, p=0.014; excluding patients who received invasive treatment). A basal MAD>47mm showed a sensitivity of 100% and a specificity of 69% while MAD≥55mm demonstrated a sensitivity of 34% and a specificity of 91% for aortic mortality during hospitalization. 
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